DEFLORIAN, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.336
AS - Asia 740
EU - Europa 360
AF - Africa 128
SA - Sud America 111
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.695
Nazione #
US - Stati Uniti d'America 1.278
SG - Singapore 237
CN - Cina 175
VN - Vietnam 120
BR - Brasile 61
DE - Germania 55
HK - Hong Kong 52
FR - Francia 45
IT - Italia 27
FI - Finlandia 25
SE - Svezia 25
CA - Canada 18
TR - Turchia 18
IE - Irlanda 17
IN - India 17
GB - Regno Unito 16
UA - Ucraina 16
AR - Argentina 14
GR - Grecia 14
RU - Federazione Russa 14
BD - Bangladesh 13
NL - Olanda 11
UZ - Uzbekistan 10
MX - Messico 9
PL - Polonia 9
EC - Ecuador 8
EG - Egitto 8
IQ - Iraq 8
ZA - Sudafrica 8
BG - Bulgaria 7
BY - Bielorussia 7
GA - Gabon 7
SA - Arabia Saudita 7
BJ - Benin 6
IS - Islanda 6
JP - Giappone 6
MA - Marocco 6
MZ - Mozambico 6
PK - Pakistan 6
UY - Uruguay 6
VE - Venezuela 6
CL - Cile 5
GM - Gambi 5
HR - Croazia 5
ID - Indonesia 5
JM - Giamaica 5
KE - Kenya 5
LU - Lussemburgo 5
RO - Romania 5
SI - Slovenia 5
UG - Uganda 5
YT - Mayotte 5
AF - Afghanistan, Repubblica islamica di 4
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BZ - Belize 4
CO - Colombia 4
CV - Capo Verde 4
DJ - Gibuti 4
DK - Danimarca 4
DZ - Algeria 4
EE - Estonia 4
JO - Giordania 4
LA - Repubblica Popolare Democratica del Laos 4
MR - Mauritania 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PF - Polinesia Francese 4
PY - Paraguay 4
RS - Serbia 4
SO - Somalia 4
TL - Timor Orientale 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AU - Australia 3
BE - Belgio 3
BW - Botswana 3
CH - Svizzera 3
ES - Italia 3
GT - Guatemala 3
HU - Ungheria 3
KR - Corea 3
KZ - Kazakistan 3
ME - Montenegro 3
MG - Madagascar 3
ML - Mali 3
MN - Mongolia 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
PG - Papua Nuova Guinea 3
PH - Filippine 3
PS - Palestinian Territory 3
RE - Reunion 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AL - Albania 2
AM - Armenia 2
Totale 2.621
Città #
Fairfield 188
Singapore 162
Ashburn 136
San Jose 106
Woodbridge 78
Dong Ket 74
Cambridge 71
Chandler 69
Santa Clara 65
Wilmington 61
Seattle 60
Houston 54
Jacksonville 54
Hong Kong 49
Beijing 34
Princeton 29
Ann Arbor 25
Columbus 21
Ho Chi Minh City 18
Dublin 16
Boardman 15
Los Angeles 15
Hanoi 12
Des Moines 11
Helsinki 11
Lauterbourg 11
San Diego 11
Tashkent 9
Yenibosna 9
North York 8
Buffalo 7
Tianjin 7
Cotonou 6
Libreville 6
Maputo 6
Montevideo 6
Nanjing 6
New York 6
Americana 5
Chicago 5
Council Bluffs 5
Jinan 5
Kampala 5
Luxembourg 5
Munich 5
Reykjavik 5
Sofia 5
São Paulo 5
Tokyo 5
Amman 4
Bytom 4
Kabul 4
Kharkiv 4
Ljubljana 4
London 4
Managua 4
Minsk 4
Montreal 4
Nanchang 4
Nouakchott 4
Philadelphia 4
Tallinn 4
Treviso 4
Vientiane 4
Warsaw 4
Baku 3
Bamako 3
Belize City 3
Boston 3
Brooklyn 3
Chennai 3
Denver 3
Dili 3
Djibouti 3
Frankfurt am Main 3
Gaborone 3
Johannesburg 3
Mamoudzou 3
Medford 3
Montréal 3
Ningbo 3
Padova 3
Phoenix 3
Port Moresby 3
Praia 3
Quito 3
Rome 3
San Juan 3
Shenyang 3
The Dalles 3
Vienna 3
Accra 2
Alexandria 2
Amsterdam 2
Antakya 2
Antananarivo 2
Astana 2
Asunción 2
Baghdad 2
Banjul 2
Totale 1.747
Nome #
1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies. 426
Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: Design of new Gly/NMDA receptor antagonists as a key study 228
Combining ligand-based and structure-based drug design in the virtual screening arena 226
G protein-coupled receptors as challenging druggable targets: insights from in silico studies 221
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: a complete structure -activity profile. 217
Ligand-based homology modeling as attractive tool to inspect GPCR structural plasticity 204
Application of a molybdenum and tungsten disulfide coating to improve tribological properties of orthodontic archwires 203
Demystifying the three dimensional structure of G protein- coupled receptors (GPCRs) with the aid of molecular modeling 200
Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies 185
Novel strategies for the design of new potent and selective human A3 receptor antagonists: an update 157
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A(3) and A(2B) adenosine receptor subtypes: A molecular modeling investigation 156
Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A(3) adenosine receptor antagonists: Pyrazolo[4,3-e]1,2,4- triazolo[1,5-c]pyrimidine derivatives as a key study 144
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists: influence of the N5 substituent on the affinity at the human A3 and A2B adenosine receptor subtypes. 135
Totale 2.702
Categoria #
all - tutte 7.468
article - articoli 7.468
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021114 0 0 0 0 0 0 0 0 0 0 34 80
2021/2022205 16 23 20 15 1 15 14 25 7 9 19 41
2022/2023166 32 15 2 19 20 41 0 10 15 2 7 3
2023/2024102 3 11 25 3 16 4 19 5 2 1 6 7
2024/2025342 0 56 12 14 67 13 22 30 9 13 49 57
2025/20261.115 29 77 177 202 150 57 112 114 106 64 27 0
Totale 2.702